Anti-obesity Properties of Phytochemicals: Highlighting their Molecular Mechanisms against Obesity
- Authors: Poulios E.1, Koukounari S.2, Psara E.3, Vasios G.3, Sakarikou C.3, Giaginis C.3
-
Affiliations:
- Department of Food Science and Nutrition, School of the Environmentof Food Science and Nutrition, University of the Aegean
- Department of Food Science and Nutrition, School of the Environment, University of the Aegean
- Department of Food Science and Nutrition, School of the Environment,, University of the Aegean
- Issue: Vol 31, No 1 (2024)
- Pages: 25-61
- Section: Anti-Infectives and Infectious Diseases
- URL: https://hum-ecol.ru/0929-8673/article/view/644111
- DOI: https://doi.org/10.2174/0929867330666230517124033
- ID: 644111
Cite item
Full Text
Abstract
Obesity is a complex, chronic and inflammatory disease that affects more than one-third of the worlds population, leading to a higher incidence of diabetes, dyslipidemia, metabolic syndrome, cardiovascular diseases, and some types of cancer. Several phytochemicals are used as flavoring and aromatic compounds, also exerting many benefits for public health. This study aims to summarize and scrutinize the beneficial effects of the most important phytochemicals against obesity. Systematic research of the current international literature was carried out in the most accurate scientific databases, e.g., Pubmed, Scopus, Web of Science and Google Scholar, using a set of critical and representative keywords, such as phytochemicals, obesity, metabolism, metabolic syndrome, etc. Several studies unraveled the potential positive effects of phytochemicals such as berberine, carvacrol, curcumin, quercetin, resveratrol, thymol, etc., against obesity and metabolic disorders. Mechanisms of action include inhibition of adipocyte differentiation, browning of the white adipose tissue, inhibition of enzymes such as lipase and amylase, suppression of inflammation, improvement of the gut microbiota, and downregulation of obesity-inducing genes. In conclusion, multiple bioactive compounds-phytochemicals exert many beneficial effects against obesity. Future molecular and clinical studies must be performed to unravel the multiple molecular mechanisms and anti-obesity activities of these naturally occurring bioactive compounds.
About the authors
Efthymios Poulios
Department of Food Science and Nutrition, School of the Environmentof Food Science and Nutrition, University of the Aegean
Email: info@benthamscience.net
Stergia Koukounari
Department of Food Science and Nutrition, School of the Environment, University of the Aegean
Email: info@benthamscience.net
Evmorfia Psara
Department of Food Science and Nutrition, School of the Environment,, University of the Aegean
Email: info@benthamscience.net
Georgios Vasios
Department of Food Science and Nutrition, School of the Environment,, University of the Aegean
Email: info@benthamscience.net
Christina Sakarikou
Department of Food Science and Nutrition, School of the Environment,, University of the Aegean
Email: info@benthamscience.net
Constantinos Giaginis
Department of Food Science and Nutrition, School of the Environment,, University of the Aegean
Author for correspondence.
Email: info@benthamscience.net
References
- Barakat, B.; Almeida, M.E.F. Biochemical and immunological changes in obesity. Arch. Biochem. Biophys., 2021, 708, 108951. doi: 10.1016/j.abb.2021.108951 PMID: 34102165
- Hruby, A.; Hu, F.B. The epidemiology of obesity: A big picture. PharmacoEconomics, 2015, 33(7), 673-689. doi: 10.1007/s40273-014-0243-x PMID: 25471927
- Jebeile, H.; Kelly, A.S.; O'Malley, G.; Baur, L.A. Obesity in children and adolescents: Epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol., 2022, 10(5), 351-365. doi: 10.1016/S2213-8587(22)00047-X
- Wallis, N.; Raffan, E. The genetic basis of obesity and related metabolic diseases in humans and companion animals. Genes, 2020, 11(11), 1378. doi: 10.3390/genes11111378 PMID: 33233816
- Włodarczyk, M.; Nowicka, G. Obesity, DNA Damage, and development of obesity-related diseases. Int. J. Mol. Sci., 2019, 20(5), 1146. doi: 10.3390/ijms20051146 PMID: 30845725
- Chiurazzi, M.; Cozzolino, M.; Orsini, R.C.; Di Maro, M.; Di Minno, M.N.D.; Colantuoni, A. Impact of Genetic variations and epigenetic mechanisms on the risk of obesity. Int. J. Mol. Sci., 2020, 21(23), 9035. doi: 10.3390/ijms21239035 PMID: 33261141
- Bouchard, C. Genetics of obesity: What we have learned over decades of research. Obesity, 2021, 29(5), 802-820. doi: 10.1002/oby.23116 PMID: 33899337
- Obri, A.; Serra, D.; Herrero, L.; Mera, P. The role of epigenetics in the development of obesity. Biochem. Pharmacol., 2020, 177, 113973. doi: 10.1016/j.bcp.2020.113973 PMID: 32283053
- Yin, L.; Zhu, X.; Novák, P.; Zhou, L.; Gao, L.; Yang, M.; Zhao, G.; Yin, K. The epitranscriptome of long noncoding RNAs in metabolic diseases. Clin. Chim. Acta, 2021, 515, 80-89. doi: 10.1016/j.cca.2021.01.001 PMID: 33422492
- Wu, D.; Wang, H.; Xie, L.; Hu, F. Cross-Talk between gut microbiota and adipose tissues in obesity and related metabolic diseases. Front. Endocrinol., 2022, 13, 908868. doi: 10.3389/fendo.2022.908868 PMID: 35865314
- Song, X.; Wang, L.; Liu, Y.; Zhang, X.; Weng, P.; Liu, L.; Zhang, R.; Wu, Z. The gut microbiotabrain axis: Role of the gut microbial metabolites of dietary food in obesity. Food Res. Int., 2022, 153, 110971. doi: 10.1016/j.foodres.2022.110971 PMID: 35227482
- Palou, A.; Bonet, M.L. Challenges in obesity research. Nutr. Hosp., 2013, 28(Suppl. 5), 144-153. doi: 10.3305/nh.2013.28.sup5.6930 PMID: 24010755
- Wen, X.; Zhang, B.; Wu, B.; Xiao, H.; Li, Z.; Li, R.; Xu, X.; Li, T. Signaling pathways in obesity: Mechanisms and therapeutic interventions. Signal Transduct. Target. Ther., 2022, 7(1), 298. doi: 10.1038/s41392-022-01149-x PMID: 36031641
- Conceição-Furber, E.; Coskun, T.; Sloop, K.W.; Samms, R.J. Is glucagon receptor activation the thermogenic solution for treating obesity? Front. Endocrinol., 2022, 13, 868037. doi: 10.3389/fendo.2022.868037 PMID: 35547006
- Reja, D.; Zhang, C.; Sarkar, A. Endoscopic bariatrics: Current therapies and future directions. Transl. Gastroenterol. Hepatol., 2022, 7, 21. doi: 10.21037/tgh.2020.03.09 PMID: 35548475
- Wang, Y.F.; Shen, Z.C.; Li, J.; Liang, T.; Lin, X.F.; Li, Y.P.; Zeng, W.; Zou, Q.; Shen, J.L.; Wang, X.Y. Phytochemicals, biological activity, and industrial application of lotus seedpod (Receptaculum Nelumbinis): A review. Front. Nutr., 2022, 9, 1022794. doi: 10.3389/fnut.2022.1022794 PMID: 36267901
- Jit, B.P.; Pattnaik, S.; Arya, R.; Dash, R.; Sahoo, S.S.; Pradhan, B.; Bhuyan, P.P.; Behera, P.K.; Jena, M.; Sharma, A.; Agrawala, P.K.; Behera, R.K. Phytochemicals: A potential next generation agent for radioprotection. Phytomedicine, 2022, 106, 154188. doi: 10.1016/j.phymed.2022.154188 PMID: 36029645
- Santhiravel, S.; Bekhit, A.EA.; Mendis, E.; Jacobs, J.L.; Dunshe, F.R.; Rajapakse, N.; Ponnampalam, E.N. The impact of plant phytochemicals on the gut microbiota of humans for a balanced life. Int J Mol Sci., 2022, 23(15), 8124. doi: 10.3390/ijms23158124
- Yisimayili, Z.; Chao, Z. A review on phytochemicals, metabolic profiles and pharmacokinetics studies of the different parts (juice, seeds, peel, flowers, leaves and bark) of pomegranate (Punica granatum L.). Food Chem., 2022, 395, 133600. doi: 10.1016/j.foodchem.2022.133600
- Shi, M.; Gu, J.; Wu, H.; Rauf, A.; Emran, T.B.; Khan, Z.; Mitra, S.; Aljohani, A.S.M.; Alhumaydhi, F.A.; Al-Awthan, Y.S.; Bahattab, O.; Thiruvengadam, M.; Suleria, H.A.R. Phytochemicals, nutrition, metabolism, bioavailability, and health benefits in Lettuce - A comprehensive review. Antioxidants, 2022, 11(6), 1158. doi: 10.3390/antiox11061158 PMID: 35740055
- Hao, J.; Gao, Y.; Xue, J.; Yang, Y.; Yin, J.; Wu, T.; Zhang, M. Phytochemicals, pharmacological effects and molecular mechanisms of mulberry. Foods, 2022, 11(8), 1170. doi: 10.3390/foods11081170 PMID: 35454757
- Poulios, E.; Giaginis, C.; Vasios, G.K. Current advances on the extraction and identification of bioactive components of sage (Salvia spp.). Curr. Pharm. Biotechnol., 2019, 20(10), 845-857. doi: 10.2174/1389201020666190722130440 PMID: 31333123
- Lim, X.Y.; The, B.P.; Tan, T.Y.C. Medicinal plants in COVID-19: Potential and limitations. Front Pharmacol., 2021, 12, 611408. doi: 10.3389/fphar.2021.611408
- Poulios, E.; Vasios, G.K.; Psara, E.; Giaginis, C. Medicinal plants consumption against urinary tract infections: A narrative review of the current evidence. Expert Rev. Anti Infect. Ther., 2021, 19(4), 519-528. doi: 10.1080/14787210.2021.1828061 PMID: 33016791
- Ayaz, M.; Ullah, F.; Sadiq, A.; Ullah, F.; Ovais, M.; Ahmed, J.; Devkota, H.P. Synergistic interactions of phytochemicals with antimicrobial agents: Potential strategy to counteract drug resistance. Chem. Biol. Interact., 2019, 308, 294-303. doi: 10.1016/j.cbi.2019.05.050 PMID: 31158333
- Gregory, J.; Vengalasetti, Y.V.; Bredesen, D.E.; Rao, R.V. Neuroprotective herbs for the management of alzheimers disease. Biomolecules, 2021, 11(4), 543. doi: 10.3390/biom11040543 PMID: 33917843
- Naoi, M.; Maruyama, W.; Shamoto-Nagai, M. Disease-modifying treatment of Parkinsons disease by phytochemicals: Targeting multiple pathogenic factors. J. Neural Transm., 2021, 2021 doi: 10.1007/s00702-021-02427-8 PMID: 34654977
- Zhao, X.; Kim, Y.R.; Min, Y.; Zhao, Y.; Do, K.; Son, Y.O. Natural plant extracts and compounds for Rheumatoid Arthritis Therapy. Medicina, 2021, 57(3), 266. doi: 10.3390/medicina57030266 PMID: 33803959
- Kumar, S.; Mittal, A.; Babu, D.; Mittal, A. Herbal medicines for diabetes management and its secondary complications. Curr. Diabetes Rev., 2021, 17(4), 437-456. doi: 10.2174/18756417MTExfMTQ1z PMID: 33143632
- Cote, B.; Elbarbry, F.; Bui, F.; Su, J.W.; Seo, K.; Nguyen, A.; Lee, M.; Rao, D.A. Mechanistic basis for the role of phytochemicals in inflammation-associated chronic diseases. Molecules, 2022, 27(3), 781. doi: 10.3390/molecules27030781 PMID: 35164043
- Aba, P.E.; Ihedioha, J.I.; Asuzu, I.U. A review of the mechanisms of anti-cancer activities of some medicinal plantsbiochemical perspectives. J. Basic Clin. Physiol. Pharmacol., 2021, 0(0) doi: 10.1515/jbcpp-2021-0257 PMID: 34936737
- Saqib, U.; Khan, M.A.; Alagumuthu, M.; Parihar, S.P.; Baig, M.S. Natural compounds as antiatherogenic agents. Cell. Mol. Biol., 2021, 67(1), 177-188. doi: 10.14715/cmb/2021.67.1.27 PMID: 34817349
- Kamyab, R.; Namdar, H.; Torbati, M.; Ghojazadeh, M.; Araj-Khodaei, M.; Fazljou, S.M.B. Medicinal plants in the treatment of hypertension: A review. Adv. Pharm. Bull., 2020, 11(4), 601-617. doi: 10.34172/apb.2021.090 PMID: 34888207
- Dincer, Y.; Yuksel, S. Antiobesity effects of phytochemicals from an epigenetic perspective. Nutrition, 2021, 84, 111119. doi: 10.1016/j.nut.2020.111119 PMID: 33476999
- Chang, Y.H.; Hung, H.Y. Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review. Eur. J. Med. Chem., 2022, 237, 114405. doi: 10.1016/j.ejmech.2022.114405 PMID: 35489224
- Ma, P.Y.; Li, X.Y.; Wang, Y.L.; Lang, D.Q.; Liu, L.; Yi, Y.K.; Liu, Q.; Shen, C.Y. Natural bioactive constituents from herbs and nutraceuticals promote browning of white adipose tissue. Pharmacol. Res., 2022, 178, 106175. doi: 10.1016/j.phrs.2022.106175 PMID: 35283301
- Li, H.; Qi, J.; Li, L. Phytochemicals as potential candidates to combat obesity via adipose non-shivering thermogenesis. Pharmacol. Res., 2019, 147, 104393. doi: 10.1016/j.phrs.2019.104393 PMID: 31401211
- Atazadegan, M.A.; Bagherniya, M.; Fakheran, O.; Sathyapalan, T.; Sahebkar, A. The effect of herbal medicine and natural bioactive compounds on plasma adiponectin: A clinical review. Adv. Exp. Med. Biol., 2021, 1328, 37-57. doi: 10.1007/978-3-030-73234-9_4 PMID: 34981470
- Hofer, S.J.; Davinelli, S.; Bergmann, M.; Scapagnini, G.; Madeo, F. Caloric restriction mimetics in nutrition and clinical trials. Front. Nutr., 2021, 8, 717343. doi: 10.3389/fnut.2021.717343 PMID: 34552954
- Xu, X.; Yi, H.; Wu, J.; Kuang, T.; Zhang, J.; Li, Q.; Du, H.; Xu, T.; Jiang, G.; Fan, G. Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomed. Pharmacother., 2021, 133, 110984. doi: 10.1016/j.biopha.2020.110984 PMID: 33186794
- Habtemariam, S. Berberine pharmacology and the gut microbiota: A hidden therapeutic link. Pharmacol. Res., 2020, 155, 104722. doi: 10.1016/j.phrs.2020.104722 PMID: 32105754
- Zhang, L.; Wu, X.; Yang, R.; Chen, F.; Liao, Y.; Zhu, Z.; Wu, Z.; Sun, X.; Wang, L. Effects of Berberine on the Gastrointestinal Microbiota. Front. Cell. Infect. Microbiol., 2021, 10, 588517. doi: 10.3389/fcimb.2020.588517 PMID: 33680978
- Sun, R.; Yang, N.; Kong, B.; Cao, B.; Feng, D.; Yu, X.; Ge, C.; Huang, J.; Shen, J.; Wang, P.; Feng, S.; Fei, F.; Guo, J.; He, J.; Aa, N.; Chen, Q.; Pan, Y.; Schumacher, J.D.; Yang, C.S.; Guo, G.L.; Aa, J.; Wang, G. Orally administered berberine modulates hepatic lipid metabolism by altering microbial bile acid metabolism and the intestinal fxr signaling pathway. Mol. Pharmacol., 2017, 91(2), 110-122. doi: 10.1124/mol.116.106617 PMID: 27932556
- Zhang, X.; Zhao, Y.; Zhang, M.; Pang, X.; Xu, J.; Kang, C.; Li, M.; Zhang, C.; Zhang, Z.; Zhang, Y.; Li, X.; Ning, G.; Zhao, L. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One, 2012, 7(8), e42529. doi: 10.1371/journal.pone.0042529 PMID: 22880019
- Ferdous, M.R.; Abdalla, M.; Yang, M.; Xiaoling, L.; Song, Y. Berberine chloride (dual topoisomerase I and II inhibitor) modulate mitochondrial uncoupling protein (UCP1) in molecular docking and dynamic with in-vitro cytotoxic and mitochondrial ATP production. J. Biomol. Struct. Dyn., 2022, 25, 1-11. doi: 10.1080/07391102.2021.2024255 PMID: 35612892
- Singh, S.; Pathak, N.; Fatima, E.; Negi, A.S. Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine. Eur. J. Med. Chem., 2021, 226, 113839. doi: 10.1016/j.ejmech.2021.113839 PMID: 34536668
- Wu, Y.Y.; Huang, X.M.; Liu, J.; Cha, Y.; Chen, Z.P.; Wang, F.; Xu, J.; Sheng, L.; Ding, H.Y. Functional study of the upregulation of miRNA-27a and miRNA-27b in 3T3-L1 cells in response to berberine. Mol. Med. Rep., 2016, 14(3), 2725-2731. doi: 10.3892/mmr.2016.5545 PMID: 27484069
- Wang, M.; Xu, R.; Liu, X.; Zhang, L.; Qiu, S.; Lu, Y.; Zhang, P.; Yan, M.; Zhu, J. A co-crystal berberine-ibuprofen improves obesity by inhibiting the protein kinases TBK1 and IKKɛ. Commun. Biol., 2022, 5(1), 807. doi: 10.1038/s42003-022-03776-0 PMID: 35962183
- Noh, J.W.; Jun, M.S.; Yang, H.K.; Lee, B.C. Cellular and molecular mechanisms and effects of berberine on obesity-induced inflammation. Biomedicines, 2022, 10(7), 1739. doi: 10.3390/biomedicines10071739 PMID: 35885044
- Han, Y.B.; Tian, M.; Wang, X.X.; Fan, D.H.; Li, W.Z.; Wu, F.; Liu, L. Berberine ameliorates obesity-induced chronic inflammation through suppression of ER stress and promotion of macrophage M2 polarization at least partly via downregulating lncRNA Gomafu. Int. Immunopharmacol., 2020, 86, 106741. doi: 10.1016/j.intimp.2020.106741 PMID: 32650294
- Ilyas, Z.; Perna, S.; Al-thawadi, S.; Alalwan, T.A.; Riva, A.; Petrangolini, G.; Gasparri, C.; Infantino, V.; Peroni, G.; Rondanelli, M. The effect of Berberine on weight loss in order to prevent obesity: A systematic review. Biomed. Pharmacother., 2020, 127, 110137. doi: 10.1016/j.biopha.2020.110137 PMID: 32353823
- Ye, Y.; Liu, X.; Wu, N.; Han, Y.; Wang, J.; Yu, Y.; Chen, Q. Efficacy and safety of berberine alone for several metabolic disorders: A systematic review and meta-analysis of randomized clinical trials. Front. Pharmacol., 2021, 12, 653887. doi: 10.3389/fphar.2021.653887 PMID: 33981233
- Xiong, P.; Niu, L.; Talaei, S.; Kord-Varkaneh, H.; Clark, C.C.T.; Găman, M.A.; Rahmani, J.; Dorosti, M.; Mousavi, S.M.; Zarezadeh, M.; Taghizade-Bilondi, H.; Zhang, J. The effect of berberine supplementation on obesity indices: A dose response meta-analysis and systematic review of randomized controlled trials. Complement. Ther. Clin. Pract., 2020, 39, 101113. doi: 10.1016/j.ctcp.2020.101113 PMID: 32379652
- Asbaghi, O.; Ghanbari, N.; shekari, M.; Reiner, .; Amirani, E.; Hallajzadeh, J.; Mirsafaei, L.; Asemi, Z. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. Clin. Nutr. ESPEN, 2020, 38, 43-49. doi: 10.1016/j.clnesp.2020.04.010 PMID: 32690176
- Wu, L.; Meng, J.; Shen, Q.; Zhang, Y.; Pan, S.; Chen, Z.; Zhu, L.Q.; Lu, Y.; Huang, Y.; Zhang, G. Caffeine inhibits hypothalamic A1R to excite oxytocin neuron and ameliorate dietary obesity in mice. Nat. Commun., 2017, 8(1), 15904. doi: 10.1038/ncomms15904 PMID: 28654087
- Dangol, M.; Kim, S.; Li, C.G.; Fakhraei Lahiji, S.; Jang, M.; Ma, Y.; Huh, I.; Jung, H. Anti-obesity effect of a novel caffeine-loaded dissolving microneedle patch in high-fat diet-induced obese C57BL/6J mice. J. Control. Release, 2017, 265, 41-47. doi: 10.1016/j.jconrel.2017.03.400 PMID: 28389409
- Kim, H.; Lee, M.; Park, H.; Park, Y.; Shon, J.; Liu, K.H.; Lee, C. Urine and serum metabolite profiling of rats fed a high-fat diet and the anti-obesity effects of caffeine consumption. Molecules, 2015, 20(2), 3107-3128. doi: 10.3390/molecules20023107 PMID: 25689639
- Xu, Y.; Zhang, M.; Wu, T.; Dai, S.; Xu, J.; Zhou, Z. The anti-obesity effect of green tea polysaccharides, polyphenols and caffeine in rats fed with a high-fat diet. Food Funct., 2015, 6(1), 296-303. doi: 10.1039/C4FO00970C PMID: 25431018
- Shanmugham, V.; Subban, R. Comparison of the Anti-Obesity Effect of Enriched Capsanthin and Capsaicin from Capsicum annuum L. Fruit in Obesity-Induced C57BL/6J Mouse Model. Food Technol. Biotechnol., 2022, 60(2), 202-212. doi: 10.17113/ftb.60.02.22.7376 PMID: 35910274
- Li, R.; Lan, Y.; Chen, C.; Cao, Y.; Huang, Q.; Ho, C.T.; Lu, M. Anti-obesity effects of capsaicin and the underlying mechanisms: A review. Food Funct., 2020, 11(9), 7356-7370. doi: 10.1039/D0FO01467B PMID: 32820787
- Wang, Y.; Tang, C.; Tang, Y.; Yin, H.; Liu, X. Capsaicin has an anti-obesity effect through alterations in gut microbiota populations and short-chain fatty acid concentrations. Food Nutr. Res., 2020, 64(0) doi: 10.29219/fnr.v64.3525 PMID: 32180694
- Kang, C.; Wang, B.; Kaliannan, K.; Wang, X.; Lang, H.; Hui, S.; Huang, L.; Zhang, Y.; Zhou, M.; Chen, M.; Mi, M. Gut microbiota mediates the protective effects of dietary capsaicin against chronic low-grade inflammation and associated obesity induced by high-fat diet. MBio, 2017, 8(3), e00470-17. doi: 10.1128/mBio.00470-17 PMID: 28536285
- Kang, J.H.; Tsuyoshi, G.; Han, I.S.; Kawada, T.; Kim, Y.M.; Yu, R. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Obesity, 2010, 18(4), 780-787. doi: 10.1038/oby.2009.301 PMID: 19798065
- Shen, W.; Shen, M.; Zhao, X.; Zhu, H.; Yang, Y.; Lu, S.; Tan, Y.; Li, G.; Li, M.; Wang, J.; Hu, F.; Le, S. Anti-obesity effect of capsaicin in mice fed with high-fat diet is associated with an increase in population of the Gut Bacterium Akkermansia muciniphila. Front. Microbiol., 2017, 8, 272. doi: 10.3389/fmicb.2017.00272 PMID: 28280490
- Baskaran, P.; Krishnan, V.; Ren, J.; Thyagarajan, B. Capsaicin induces browning of white adipose tissue and counters obesity by activating TRPV1 channel-dependent mechanisms. Br. J. Pharmacol., 2016, 173(15), 2369-2389. doi: 10.1111/bph.13514 PMID: 27174467
- Lu, M.; Cao, Y.; Ho, C.T.; Huang, Q. The enhanced anti-obesity effect and reduced gastric mucosa irritation of capsaicin-loaded nanoemulsions. Food Funct., 2017, 8(5), 1803-1809. doi: 10.1039/C7FO00173H PMID: 28443906
- Zheng, J.; Zheng, S.; Feng, Q.; Zhang, Q.; Xiao, X. Dietary capsaicin and its anti-obesity potency: From mechanism to clinical implications. Biosci. Rep., 2017, 37(3), BSR20170286. doi: 10.1042/BSR20170286 PMID: 28424369
- Fattori, V.; Hohmann, M.; Rossaneis, A.; Pinho-Ribeiro, F.; Verri, W. Capsaicin: Current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses. Molecules, 2016, 21(7), 844. doi: 10.3390/molecules21070844 PMID: 27367653
- Leung, F.W. Capsaicin as an anti-obesity drug. Prog. Drug Res., 2014, 68, 171-179. doi: 10.1007/978-3-0348-0828-6_7 PMID: 24941669
- Zsiborás, C.; Mátics, R.; Hegyi, P.; Balaskó, M.; Pétervári, E.; Szabó, I.; Sarlós, P.; Mikó, A.; Tenk, J.; Rostás, I.; Pécsi, D.; Garami, A.; Rumbus, Z.; Huszár, O.; Solymár, M. Capsaicin and capsiate could be appropriate agents for treatment of obesity: A meta-analysis of human studies. Crit. Rev. Food Sci. Nutr., 2018, 58(9), 1419-1427. doi: 10.1080/10408398.2016.1262324 PMID: 28001433
- Shi, X.D.; Zhang, J.X.; Hu, X.D.; Zhuang, T.; Lu, N.; Ruan, C.C. Leonurine attenuates obesity-related vascular dysfunction and inflammation. Antioxidants, 2022, 11(7), 1338. doi: 10.3390/antiox11071338 PMID: 35883829
- Kotha, R.R.; Luthria, D.L. Curcumin: Biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules, 2019, 24(16), 2930. doi: 10.3390/molecules24162930 PMID: 31412624
- Zhao, Y.; Chen, B.; Shen, J.; Wan, L.; Zhu, Y.; Yi, T.; Xiao, Z. The beneficial effects of Quercetin, Curcumin, and Resveratrol in obesity. Oxid. Med. Cell. Longev., 2017, 2017, 1-8. doi: 10.1155/2017/1459497 PMID: 29138673
- Martínez-Morúa, A.; Soto-Urquieta, M.G.; Franco-Robles, E.; Zúñiga-Trujillo, I.; Campos-Cervantes, A.; Pérez-Vázquez, V.; Ramírez-Emiliano, J. Curcumin decreases oxidative stress in mitochondria isolated from liver and kidneys of high-fat diet-induced obese mice. J. Asian Nat. Prod. Res., 2013, 15(8), 905-915. doi: 10.1080/10286020.2013.802687 PMID: 23782307
- Ariamoghaddam, A.; Ebrahimi-Hosseinzadeh, B.; Hatamian-Zarmi, A.; Sahraeian, R. In vivo anti-obesity efficacy of curcumin loaded nanofibers transdermal patches in high-fat diet induced obese rats. Mater. Sci. Eng. C, 2018, 92, 161-171. doi: 10.1016/j.msec.2018.06.030 PMID: 30184739
- Bradford, P.G. Curcumin and obesity. Biofactors, 2013, 39(1), 78-87. doi: 10.1002/biof.1074 PMID: 23339049
- Pan, S.; Chen, Y.; Zhang, L.; Liu, Z.; Xu, X.; Xing, H. Curcumin represses lipid accumulation through inhibiting ERK1/2-PPAR-γ signaling pathway and triggering apoptosis in porcine subcutaneous preadipocytes. Animal Bioscience, 2022, 35(5), 763-777. doi: 10.5713/ab.21.0371 PMID: 34727633
- Maithilikarpagaselvi, N.; Sridhar, M.G.; Swaminathan, R.P.; Sripradha, R. Preventive effect of curcumin on inflammation, oxidative stress and insulin resistance in high-fat fed obese rats. J. Complement. Integr. Med., 2016, 13(2), 137-143. doi: 10.1515/jcim-2015-0070 PMID: 26845728
- Mokgalaboni, K.; Ntamo, Y.; Ziqubu, K.; Nyambuya, T.M.; Nkambule, B.B.; Mazibuko-Mbeje, S.E.; Gabuza, K.B.; Chellan, N.; Tiano, L.; Dludla, P.V. Curcumin supplementation improves biomarkers of oxidative stress and inflammation in conditions of obesity, type 2 diabetes and NAFLD: Updating the status of clinical evidence. Food Funct., 2021, 12(24), 12235-12249. doi: 10.1039/D1FO02696H PMID: 34847213
- Kobori, M.; Takahashi, Y.; Takeda, H.; Takahashi, M.; Izumi, Y.; Akimoto, Y.; Sakurai, M.; Oike, H.; Nakagawa, T.; Itoh, M.; Bamba, T.; Kimura, T. Dietary intake of curcumin improves eif2 signaling and reduces lipid levels in the white adipose tissue of obese mice. Sci. Rep., 2018, 8(1), 9081. doi: 10.1038/s41598-018-27105-w PMID: 29899429
- Wu, L.Y.; Chen, C.W.; Chen, L.K.; Chou, H.Y.; Chang, C.L.; Juan, C.C. Curcumin Attenuates adipogenesis by inducing preadipocyte apoptosis and inhibiting adipocyte differentiation. Nutrients, 2019, 11(10), 2307. doi: 10.3390/nu11102307 PMID: 31569380
- Tian, L.; Song, Z.; Shao, W.; Du, W.W.; Zhao, L.R.; Zeng, K.; Yang, B.B.; Jin, T. Curcumin represses mouse 3T3-L1 cell adipogenic differentiation via inhibiting miR-17-5p and stimulating the Wnt signalling pathway effector Tcf7l2. Cell Death Dis., 2017, 8(1), e2559. doi: 10.1038/cddis.2016.455 PMID: 28102847
- Zhao, D.; Pan, Y.; Yu, N.; Bai, Y.; Ma, R.; Mo, F.; Zuo, J.; Chen, B.; Jia, Q.; Zhang, D.; Liu, J.; Jiang, G.; Gao, S. Curcumin improves adipocytes browning and mitochondrial function in 3T3-L1 cells and obese rodent model. R. Soc. Open Sci., 2021, 8(3), 200974. doi: 10.1098/rsos.200974 PMID: 33959308
- Sakuma, S.; Sumida, M.; Endoh, Y.; Kurita, A.; Yamaguchi, A.; Watanabe, T.; Kohda, T.; Tsukiyama, Y.; Fujimoto, Y. Curcumin inhibits adipogenesis induced by benzyl butyl phthalate in 3T3-L1 cells. Toxicol. Appl. Pharmacol., 2017, 329, 158-164. doi: 10.1016/j.taap.2017.05.036 PMID: 28595985
- Chen, Y.; Wu, R.; Chen, W.; Liu, Y.; Liao, X.; Zeng, B.; Guo, G.; Lou, F.; Xiang, Y.; Wang, Y.; Wang, X. Curcumin prevents obesity by targeting TRAF4-induced ubiquitylation in m 6 A-dependent manner. EMBO Rep., 2021, 22(5), e52146. doi: 10.15252/embr.202052146 PMID: 33880847
- Ferguson, B.S.; Nam, H.; Morrison, R.F. Curcumin inhibits 3T3-L1 preadipocyte proliferation by mechanisms involving post-transcriptional p27 regulation. Biochem. Biophys. Rep., 2016, 5, 16-21. doi: 10.1016/j.bbrep.2015.11.014 PMID: 26688832
- Zhu, L.; Han, M.B.; Gao, Y.; Wang, H.; Dai, L.; Wen, Y.; Na, L.X. Curcumin triggers apoptosis via upregulation of Bax/Bcl-2 ratio and caspase activation in SW872 human adipocytes. Mol. Med. Rep., 2015, 12(1), 1151-1156. doi: 10.3892/mmr.2015.3450 PMID: 25760477
- Valentine, C.; Ohnishi, K.; Irie, K.; Murakami, A. Curcumin may induce lipolysis via proteo-stress in Huh7 human hepatoma cells. J. Clin. Biochem. Nutr., 2019, 65(2), 91-98. doi: 10.3164/jcbn.19-7 PMID: 31592057
- Zingg, J.M.; Hasan, S.T.; Nakagawa, K.; Canepa, E.; Ricciarelli, R.; Villacorta, L.; Azzi, A.; Meydani, M. Modulation of cAMP levels by high-fat diet and curcumin and regulatory effects on CD36/FAT scavenger receptor/fatty acids transporter gene expression. Biofactors, 2017, 43(1), 42-53. doi: 10.1002/biof.1307 PMID: 27355903
- Ding, L.; Li, J.; Song, B.; Xiao, X.; Zhang, B.; Qi, M.; Huang, W.; Yang, L.; Wang, Z. Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway. Toxicol. Appl. Pharmacol., 2016, 304, 99-109. doi: 10.1016/j.taap.2016.05.011 PMID: 27208389
- Shen, L.; Liu, L.; Ji, H.F. Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications. Food Nutr. Res., 2017, 61(1), 1361780. doi: 10.1080/16546628.2017.1361780 PMID: 28814952
- Islam, T.; Koboziev, I.; Albracht-Schulte, K.; Mistretta, B.; Scoggin, S.; Yosofvand, M.; Moussa, H.; Zabet-Moghaddam, M.; Ramalingam, L.; Gunaratne, P.H.; Moustaid-Moussa, N. Curcumin reduces adipose tissue inflammation and alters gut microbiota in diet-induced obese male mice. Mol. Nutr. Food Res., 2021, 65(22), 2100274. doi: 10.1002/mnfr.202100274 PMID: 34510720
- Li, S.; You, J.; Wang, Z.; Liu, Y.; Wang, B.; Du, M.; Zou, T. Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in association with modulation of gut microbiota in mice. Food Res. Int., 2021, 143, 110270. doi: 10.1016/j.foodres.2021.110270 PMID: 33992371
- Han, Z.; Yao, L.; Zhong, Y.; Xiao, Y.; Gao, J.; Zheng, Z.; Fan, S.; Zhang, Z.; Gong, S.; Chang, S.; Cui, X.; Cai, J. Gut microbiota mediates the effects of curcumin on enhancing Ucp1-dependent thermogenesis and improving high-fat diet-induced obesity. Food Funct., 2021, 12(14), 6558-6575. doi: 10.1039/D1FO00671A PMID: 34096956
- Al-Saud, N.B.S. Impact of curcumin treatment on diabetic albino rats. Saudi J. Biol. Sci., 2020, 27(2), 689-694. doi: 10.1016/j.sjbs.2019.11.037 PMID: 32210689
- Shabbir, U.; Rubab, M.; Daliri, E.B.M.; Chelliah, R.; Javed, A.; Oh, D.H. Curcumin, Quercetin, Catechins and Metabolic Diseases: The Role of Gut Microbiota. Nutrients, 2021, 13(1), 206. doi: 10.3390/nu13010206 PMID: 33445760
- Koboziev, I.; Scoggin, S.; Gong, X.; Mirzaei, P.; Zabet-Moghaddam, M.; Yosofvand, M.; Moussa, H.; Jones-Hall, Y.; Moustaid-Moussa, N. Effects of curcumin in a mouse model of very high fat diet-induced obesity. Biomolecules, 2020, 10(10), 1368. doi: 10.3390/biom10101368 PMID: 32992936
- Costa, M.C.; Lima, T.F.O.; Arcaro, C.A.; Inacio, M.D.; Batista-Duharte, A.; Carlos, I.Z.; Spolidorio, L.C.; Assis, R.P.; Brunetti, I.L.; Baviera, A.M. Trigonelline and curcumin alone, but not in combination, counteract oxidative stress and inflammation and increase glycation product detoxification in the liver and kidney of mice with high-fat diet-induced obesity. J. Nutr. Biochem., 2020, 76, 108303. doi: 10.1016/j.jnutbio.2019.108303 PMID: 31812909
- Ganjali, S.; Sahebkar, A.; Mahdipour, E.; Jamialahmadi, K.; Torabi, S.; Akhlaghi, S.; Ferns, G.; Parizadeh, S.M.R.; Ghayour-Mobarhan, M. Investigation of the effects of curcumin on serum cytokines in obese individuals : A randomized controlled trial. Sci. World J., 2014, 2014, 1-6. doi: 10.1155/2014/898361 PMID: 24678280
- Alsharif, F.J.; Almuhtadi, Y.A. The effect of curcumin supplementation on anthropometric measures among overweight or obese adults. Nutrients, 2021, 13(2), 680. doi: 10.3390/nu13020680 PMID: 33672680
- Sangouni, A.A.; Taghdir, M.; Mirahmadi, J.; Sepandi, M.; Parastouei, K. Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: A randomized clinical trial. Nutr. J., 2022, 21(1), 62. doi: 10.1186/s12937-022-00816-7 PMID: 36192751
- Nurcahyanti, A.D.R.; Cokro, F.; Wulanjati, M.P.; Mahmoud, M.F.; Wink, M.; Sobeh, M. Curcuminoids for metabolic syndrome: Meta-Analysis evidences toward personalized prevention and treatment management. Front. Nutr., 2022, 9, 891339. doi: 10.3389/fnut.2022.891339 PMID: 35757255
- Vafaeipour, Z.; Razavi, B.M.; Hosseinzadeh, H. Effects of turmeric (Curcuma longa) and its constituent (curcumin) on the metabolic syndrome: An updated review. J. Integr. Med., 2022, 20(3), 193-203. doi: 10.1016/j.joim.2022.02.008 PMID: 35292209
- Hellmann, P.H.; Bagger, J.I.; Carlander, K.R.; Forman, J.; Chabanova, E.; Svenningsen, J.S.; Holst, J.J.; Gillum, M.P.; Vilsbøll, T.; Knop, F.K. The effect of curcumin on hepatic fat content in individuals with obesity. Diabetes Obes. Metab., 2022, 24(11), 2192-2202. doi: 10.1111/dom.14804 PMID: 35775631
- Karandish, M.; Mozaffari-khosravi, H.; Mohammadi, S.M.; Cheraghian, B.; Azhdari, M. Curcumin and zinc co-supplementation along with a loss-weight diet can improve lipid profiles in subjects with prediabetes: A multi-arm, parallel-group, randomized, double-blind placebo-controlled phase 2 clinical trial. Diabetol. Metab. Syndr., 2022, 14(1), 22. doi: 10.1186/s13098-022-00792-2 PMID: 35090529
- Nosrati-Oskouie, M.; Aghili-Moghaddam, N.S.; Sathyapalan, T.; Sahebkar, A. Impact of curcumin on fatty acid metabolism. Phytother. Res., 2021, 35(9), 4748-4762. doi: 10.1002/ptr.7105 PMID: 33825246
- Pourhabibi-Zarandi, F.; Rafraf, M.; Zayeni, H.; Asghari-Jafarabadi, M.; Ebrahimi, A.A. Effects of curcumin supplementation on metabolic parameters, inflammatory factors and obesity values in women with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial. Phytother. Res., 2022, 36(4), 1797-1806. doi: 10.1002/ptr.7422 PMID: 35178811
- Safari, Z.; Bagherniya, M.; Askari, G.; Sathyapalan, T.; Sahebkar, A. The effect of curcumin supplemsentation on anthropometric indices in overweight and obese individuals: A systematic review of randomized controlled trials. Adv. Exp. Med. Biol., 2021, 1291, 121-137. doi: 10.1007/978-3-030-56153-6_7 PMID: 34331687
- Obeid, M.A.; Alsaadi, M.; Aljabali, A.A. Recent updates in curcumin delivery. J. Liposome Res., 2022, 14, 1-12. doi: 10.1080/08982104.2022.2086567 PMID: 35699160
- Suzuki, T.; Pervin, M.; Goto, S.; Isemura, M.; Nakamura, Y. Beneficial effects of tea and the Green Tea Catechin Epigallocatechin-3-gallate on Obesity. Molecules, 2016, 21(10), 1305. doi: 10.3390/molecules21101305 PMID: 27689985
- Sampath, C.; Rashid, M.R.; Sang, S.; Ahmedna, M. Green tea epigallocatechin 3-gallate alleviates hyperglycemia and reduces advanced glycation end products via nrf2 pathway in mice with high fat diet-induced obesity. Biomed. Pharmacother., 2017, 87, 73-81. doi: 10.1016/j.biopha.2016.12.082 PMID: 28040599
- Sun, X.; Dey, P.; Bruno, R.S.; Zhu, J. EGCG and catechin relative to green tea extract differentially modulate the gut microbial metabolome and liver metabolome to prevent obesity in mice fed a high-fat diet. J. Nutr. Biochem., 2022, 109, 109094. doi: 10.1016/j.jnutbio.2022.109094 PMID: 35777589
- Sheng, L.; Jena, P.K.; Liu, H.X.; Hu, Y.; Nagar, N.; Bronner, D.N.; Settles, M.L.; Baümler, A.J.; Wan, Y.J.Y. Obesity treatment by epigallocatechin-3-gallate−regulated bile acid signaling and its enriched Akkermansia muciniphila. FASEB J., 2018, 32(12), 6371-6384. doi: 10.1096/fj.201800370R PMID: 29882708
- Gu, Q.; Wang, X.; Xie, L.; Yao, X.; Qian, L.; Yu, Z.; Shen, X. Green tea catechin EGCG could prevent obesity-related precocious puberty through NKB/NK3R signaling pathway. J. Nutr. Biochem., 2022, 108, 109085. doi: 10.1016/j.jnutbio.2022.109085 PMID: 35691596
- Byun, J.K.; Yoon, B.Y.; Jhun, J.Y.; Oh, H.J.; Kim, E.; Min, J.K.; Cho, M.L. Epigallocatechin-3-gallate ameliorates both obesity and autoinflammatory arthritis aggravated by obesity by altering the balance among CD4+ T-cell subsets. Immunol. Lett., 2014, 157(1-2), 51-59. doi: 10.1016/j.imlet.2013.11.006 PMID: 24239847
- Chen, Y.K.; Cheung, C.; Reuhl, K.R.; Liu, A.B.; Lee, M.J.; Lu, Y.P.; Yang, C.S. Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice. J. Agric. Food Chem., 2011, 59(21), 11862-11871. doi: 10.1021/jf2029016 PMID: 21932846
- Nicoletti, C.F.; Delfino, H.B.P.; Pinhel, M.; Noronha, N.Y.; Pinhanelli, V.C.; Quinhoneiro, D.C.G.; de Oliveira, B.A.P.; Marchini, J.S.; Nonino, C.B. Impact of green tea epigallocatechin-3-gallate on HIF1-α and mTORC2 expression in obese women: Anti-cancer and anti-obesity effects? Nutr. Hosp., 2019, 36(2), 315-320. doi: 10.20960/nh.2216
- Xiong, H.; Wang, J.; Ran, Q.; Lou, G.; Peng, C.; Gan, Q.; Hu, J.; Sun, J.; Yao, R.; Huang, Q. Hesperidin: A therapeutic agent for obesity. Drug Des. Devel. Ther., 2019, 13, 3855-3866. doi: 10.2147/DDDT.S227499 PMID: 32009777
- Park, U.H.; Hwang, J.T.; Youn, H.; Kim, E.J.; Um, S.J. Kaempferol antagonizes adipogenesis by repressing histone H3K4 methylation at PPARγ target genes. Biochem. Biophys. Res. Commun., 2022, 617(Pt 1), 48-54. doi: 10.1016/j.bbrc.2022.05.098 PMID: 35679710
- Romero-Juárez, P.A.; Visco, D.B.; Manhães-de-Castro, R.; Urquiza-Martínez, M.V.; Saavedra, L.M.; González-Vargas, M.C.; Mercado-Camargo, R.; Aquino, J.S.; Toscano, A.E.; Torner, L.; Guzmán-Quevedo, O. Dietary flavonoid kaempferol reduces obesity-associated hypothalamic microglia activation and promotes body weight loss in mice with obesity. Nutr. Neurosci., 2021, 14, 1-15. doi: 10.1080/1028415X.2021.2012629 PMID: 34905445
- Bian, Y.; Lei, J.; Zhong, J.; Wang, B.; Wan, Y.; Li, J.; Liao, C.; He, Y.; Liu, Z.; Ito, K.; Zhang, B. Kaempferol reduces obesity, prevents intestinal inflammation, and modulates gut microbiota in high-fat diet mice. J. Nutr. Biochem., 2022, 99, 108840. doi: 10.1016/j.jnutbio.2021.108840 PMID: 34419569
- Wang, T.; Wu, Q.; Zhao, T. Preventive effects of Kaempferol on High-Fat Diet-Induced obesity complications in C57BL/6 Mice. BioMed Res. Int., 2020, 2020, 1-9. doi: 10.1155/2020/4532482 PMID: 32337249
- Zang, Y.; Zhang, L.; Igarashi, K.; Yu, C. The anti-obesity and anti-diabetic effects of kaempferol glycosides from unripe soybean leaves in high-fat-diet mice. Food Funct., 2015, 6(3), 834-841. doi: 10.1039/C4FO00844H PMID: 25599885
- Torres-Villarreal, D.; Camacho, A.; Castro, H.; Ortiz-Lopez, R.; de la Garza, A.L. Anti-obesity effects of kaempferol by inhibiting adipogenesis and increasing lipolysis in 3T3-L1 cells. J. Physiol. Biochem., 2019, 75(1), 83-88. doi: 10.1007/s13105-018-0659-4 PMID: 30539499
- Deepika; Maurya, P.K. Health benefits of Quercetin in age-related diseases. Molecules, 2022, 27(8), 2498. doi: 10.3390/molecules27082498 PMID: 35458696
- Hosseini, A.; Razavi, B.M.; Banach, M.; Hosseinzadeh, H. Quercetin and metabolic syndrome: A review. Phytother. Res., 2021, 35(10), 5352-5364. doi: 10.1002/ptr.7144 PMID: 34101925
- Nettore, I.C.; Rocca, C.; Mancino, G.; Albano, L.; Amelio, D.; Grande, F.; Puoci, F.; Pasqua, T.; Desiderio, S.; Mazza, R.; Terracciano, D.; Colao, A.; Bèguinot, F.; Russo, G.L.; Dentice, M.; Macchia, P.E.; Sinicropi, M.S.; Angelone, T.; Ungaro, P. Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats. J. Nutr. Biochem., 2019, 69, 151-162. doi: 10.1016/j.jnutbio.2019.03.019 PMID: 31096072
- Seo, M.J.; Lee, Y.J.; Hwang, J.H.; Kim, K.J.; Lee, B.Y. The inhibitory effects of quercetin on obesity and obesity-induced inflammation by regulation of MAPK signaling. J. Nutr. Biochem., 2015, 26(11), 1308-1316. doi: 10.1016/j.jnutbio.2015.06.005 PMID: 26277481
- Dong, J.; Zhang, X.; Zhang, L.; Bian, H.X.; Xu, N.; Bao, B.; Liu, J. Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: A mechanism including AMPKα1/SIRT1. J. Lipid Res., 2014, 55(3), 363-374. doi: 10.1194/jlr.M038786 PMID: 24465016
- Griffin, L.E.; Essenmacher, L.; Racine, K.C.; Iglesias-Carres, L.; Tessem, J.S.; Smith, S.M.; Neilson, A.P. Diet-induced obesity in genetically diverse collaborative cross mouse founder strains reveals diverse phenotype response and amelioration by quercetin treatment in 129S1/SvImJ, PWK/EiJ, CAST/PhJ, and WSB/EiJ mice. J. Nutr. Biochem., 2021, 87, 108521. doi: 10.1016/j.jnutbio.2020.108521 PMID: 33039581
- Juárez-Fernández, M.; Porras, D.; Petrov, P.; Román-Sagüillo, S.; García-Mediavilla, M.V.; Soluyanova, P.; Martínez-Flórez, S.; González-Gallego, J.; Nistal, E.; Jover, R.; Sánchez-Campos, S. The synbiotic combination of Akkermansia muciniphila and Quercetin Ameliorates early obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation. Antioxidants, 2021, 10(12), 2001. doi: 10.3390/antiox10122001 PMID: 34943104
- Tan, Y.; Tam, C.C.; Rolston, M.; Alves, P.; Chen, L.; Meng, S.; Hong, H.; Chang, S.K.C.; Yokoyama, W. Quercetin ameliorates insulin resistance and restores gut microbiome in mice on high-fat diets. Antioxidants, 2021, 10(8), 1251. doi: 10.3390/antiox10081251 PMID: 34439499
- Liu, E.; Tsuboi, H.; Ikegami, S.; Kamiyama, T.; Asami, Y.; Ye, L.; Oda, M.; Ji, Z.S. Effects of Nelumbo nucifera Leaf Extract on Obesity. Plant Foods Hum. Nutr., 2021, 76(3), 377-384. doi: 10.1007/s11130-020-00852-w PMID: 34462872
- DEsposito, V.; Ambrosio, M.R.; Liguoro, D.; Perruolo, G.; Lecce, M.; Cabaro, S.; Aprile, M.; Marino, A.; Pilone, V.; Forestieri, P.; Miele, C.; Bruzzese, D.; Terracciano, D.; Beguinot, F.; Formisano, P. In severe obesity, subcutaneous adipose tissue cell-derived cytokines are early markers of impaired glucose tolerance and are modulated by quercetin. Int. J. Obes., 2021, 45(8), 1811-1820. doi: 10.1038/s41366-021-00850-1 PMID: 33993191
- Pei, Y.; Otieno, D.; Gu, I.; Lee, S.O.; Parks, J.S.; Schimmel, K.; Kang, H.W. Effect of quercetin on nonshivering thermogenesis of brown adipose tissue in high-fat diet-induced obese mice. J. Nutr. Biochem., 2021, 88, 108532. doi: 10.1016/j.jnutbio.2020.108532 PMID: 33130188
- Jiang, H.; Horiuchi, Y.; Hironao, K.; Kitakaze, T.; Yamashita, Y.; Ashida, H. Prevention effect of quercetin and its glycosides on obesity and hyperglycemia through activating AMPKα in high-fat diet-fed ICR mice. J. Clin. Biochem. Nutr., 2020, 67(1), 75-83. doi: 10.3164/jcbn.20-47 PMID: 32801472
- Yang, L.; Li, X.F.; Gao, L.; Zhang, Y.O.; Cai, G.P. Suppressive effects of quercetin-3-O-(6″-Feruloyl)-β-D-galactopyranoside on adipogenesis in 3T3-L1 preadipocytes through down-regulation of PPARγ and C/EBPα expression. Phytother. Res., 2012, 26(3), 438-444. doi: 10.1002/ptr.3604 PMID: 21833993
- Selek Aksoy, I.; Otles, S. Effects of green apple (Golden Delicious) and its three major flavonols consumption on obesity, lipids, and oxidative stress in obese rats. Molecules, 2022, 27(4), 1243. doi: 10.3390/molecules27041243 PMID: 35209038
- Khan, F.A.; Maalik, A.; Murtaza, G. Inhibitory mechanism against oxidative stress of caffeic acid. J. Food Drug Anal., 2016, 24(4), 695-702. doi: 10.1016/j.jfda.2016.05.003 PMID: 28911606
- Shin, S.H.; Seo, S.G.; Min, S.; Yang, H.; Lee, E.; Son, J.E.; Kwon, J.Y.; Yue, S.; Chung, M.Y.; Kim, K.H.; Cheng, J.X.; Lee, H.J.; Lee, K.W. Caffeic acid phenethyl ester, a major component of propolis, suppresses high fat diet-induced obesity through inhibiting adipogenesis at the mitotic clonal expansion stage. J. Agric. Food Chem., 2014, 62(19), 4306-4312. doi: 10.1021/jf405088f PMID: 24611533
- Liao, C.C.; Ou, T.T.; Wu, C.H.; Wang, C.J. Prevention of diet-induced hyperlipidemia and obesity by caffeic acid in C57BL/6 mice through regulation of hepatic lipogenesis gene expression. J. Agric. Food Chem., 2013, 61(46), 11082-11088. doi: 10.1021/jf4026647 PMID: 24156384
- Kumar, R.; Sharma, A.; Iqbal, M.S.; Srivastava, J.K. Therapeutic promises of chlorogenic acid with special emphasis on its anti-obesity property. Curr. Mol. Pharmacol., 2020, 13(1), 7-16. doi: 10.2174/1874467212666190716145210 PMID: 31333144
- Shao, W.; Xu, J.; Xu, C.; Weng, Z.; Liu, Q.; Zhang, X.; Liang, J.; Li, W.; Zhang, Y.; Jiang, Z.; Gu, A. Early-life perfluorooctanoic acid exposure induces obesity in male offspring and the intervention role of chlorogenic acid. Environ. Pollut., 2021, 272, 115974. doi: 10.1016/j.envpol.2020.115974 PMID: 33218772
- He, X.; Zheng, S.; Sheng, Y.; Miao, T.; Xu, J.; Xu, W.; Huang, K.; Zhao, C. Chlorogenic acid ameliorates obesity by preventing energy balance shift in high-fat diet induced obese mice. J. Sci. Food Agric., 2021, 101(2), 631-637. doi: 10.1002/jsfa.10675 PMID: 32683698
- Wang, Z.; Lam, K.L.; Hu, J.; Ge, S.; Zhou, A.; Zheng, B.; Zeng, S.; Lin, S. Chlorogenic acid alleviates obesity and modulates gut microbiota in high-fat-fed mice. Food Sci. Nutr., 2019, 7(2), 579-588. doi: 10.1002/fsn3.868 PMID: 30847137
- Ghadieh, H.E.; Smiley, Z.N.; Kopfman, M.W.; Najjar, M.G.; Hake, M.J.; Najjar, S.M. Chlorogenic acid/chromium supplement rescues diet-induced insulin resistance and obesity in mice. Nutr. Metab., 2015, 12(1), 19. doi: 10.1186/s12986-015-0014-5 PMID: 26045713
- Tang, S.; Fang, C.; Liu, Y.; Tang, L.; Xu, Y. Anti-obesity and Anti-diabetic Effect of Ursolic Acid against Streptozotocin/High Fat Induced Obese in Diabetic Rats. J. Oleo Sci., 2022, 71(2), 289-300. doi: 10.5650/jos.ess21258 PMID: 35034940
- González-Garibay, A.S.; López-Vázquez, A.; García-Bañuelos, J.; Sánchez-Enríquez, S.; Sandoval-Rodríguez, A.S.; Del Toro Arreola, S.; Bueno-Topete, M.R.; Muñoz-Valle, J.F.; González Hita, M.E.; Domínguez-Rosales, J.A.; Armendáriz-Borunda, J.; Bastidas-Ramírez, B.E. Effect of ursolic acid on insulin resistance and hyperinsulinemia in rats with diet-induced obesity: Role of adipokines expression. J. Med. Food, 2020, 23(3), 297-304. doi: 10.1089/jmf.2019.0154 PMID: 31747348
- Nguyen, H.N.; Ahn, Y.J.; Medina, E.A.; Asmis, R. Dietary 23hydroxy ursolic acid protects against atherosclerosis and obesity by preventing dyslipidemia-induced monocyte priming and dysfunction. Atherosclerosis, 2018, 275, 333-341. doi: 10.1016/j.atherosclerosis.2018.06.882 PMID: 30015296
- Rao, V.S.; de Melo, C.L.; Queiroz, M.G.R.; Lemos, T.L.G.; Menezes, D.B.; Melo, T.S.; Santos, F.A. Ursolic acid, a pentacyclic triterpene from Sambucus australis, prevents abdominal adiposity in mice fed a high-fat diet. J. Med. Food, 2011, 14(11), 1375-1382. doi: 10.1089/jmf.2010.0267 PMID: 21612453
- Kunkel, S.D.; Elmore, C.J.; Bongers, K.S.; Ebert, S.M.; Fox, D.K.; Dyle, M.C.; Bullard, S.A.; Adams, C.M. Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PLoS One, 2012, 7(6), e39332. doi: 10.1371/journal.pone.0039332 PMID: 22745735
- Feng, Y.; Huang, S.; Dou, W.; Zhang, S.; Chen, J.; Shen, Y.; Shen, J.; Leng, Y. Emodin, a natural product, selectively inhibits 11β-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice. Br. J. Pharmacol., 2010, 161(1), 113-126. doi: 10.1111/j.1476-5381.2010.00826.x PMID: 20718744
- Singh, A.P.; Singh, R.; Verma, S.S.; Rai, V.; Kaschula, C.H.; Maiti, P.; Gupta, S.C. Health benefits of resveratrol: Evidence from clinical studies. Med. Res. Rev., 2019, 39(5), 1851-1891. doi: 10.1002/med.21565 PMID: 30741437
- Barber, T.M.; Kabisch, S.; Randeva, H.S.; Pfeiffer, A.F.H.; Weickert, M.O. Implications of resveratrol in obesity and insulin resistance: A state-of-the-art review. Nutrients, 2022, 14(14), 2870. doi: 10.3390/nu14142870 PMID: 35889827
- Kim, O.Y.; Chung, J.Y.; Song, J. Effect of resveratrol on adipokines and myokines involved in fat browning: Perspectives in healthy weight against obesity. Pharmacol. Res., 2019, 148, 104411. doi: 10.1016/j.phrs.2019.104411 PMID: 31449976
- Zu, Y.; Zhao, L.; Hao, L.; Mechref, Y.; Zabet-Moghaddam, M.; Keyel, P.A.; Abbasi, M.; Wu, D.; Dawson, J.A.; Zhang, R.; Nie, S.; Moustaid-Moussa, N.; Kolonin, M.G.; Daquinag, A.C.; Brandi, L.; Warraich, I.; San Francisco, S.K.; Sun, X.; Fan, Z.; Wang, S. Browning white adipose tissue using adipose stromal cell-targeted resveratrol-loaded nanoparticles for combating obesity. J. Control. Release, 2021, 333, 339-351. doi: 10.1016/j.jconrel.2021.03.022 PMID: 33766692
- Hu, D.; Yang, W.; Mao, P.; Cheng, M. Combined Amelioration of Prebiotic Resveratrol and Probiotic Bifidobacteria on Obesity and Nonalcoholic Fatty Liver Disease. Nutr. Cancer, 2021, 73(4), 652-661. doi: 10.1080/01635581.2020.1767166 PMID: 32436410
- Gómez-Zorita, S.; Fernández-Quintela, A.; Lasa, A.; Hijona, E.; Bujanda, L.; Portillo, M.P. Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats. Nutrition, 2013, 29(11-12), 1374-1380. doi: 10.1016/j.nut.2013.04.014 PMID: 24012391
- Wang, S.; Moustaid-Moussa, N.; Chen, L.; Mo, H.; Shastri, A.; Su, R.; Bapat, P.; Kwun, I.; Shen, C.L. Novel insights of dietary polyphenols and obesity. J. Nutr. Biochem., 2014, 25(1), 1-18. doi: 10.1016/j.jnutbio.2013.09.001 PMID: 24314860
- Szkudelska, K.; Szkudelski, T. Resveratrol, obesity and diabetes. Eur. J. Pharmacol., 2010, 635(1-3), 1-8. doi: 10.1016/j.ejphar.2010.02.054 PMID: 20303945
- Carpéné, C.; Les, F.; Cásedas, G.; Peiro, C.; Fontaine, J.; Chaplin, A.; Mercader, J.; López, V. Resveratrol anti-obesity effects: Rapid inhibition of adipocyte glucose utilization. Antioxidants, 2019, 8(3), 74. doi: 10.3390/antiox8030074 PMID: 30917543
- Fraiz, G.M.; da Conceição, A.R.; de Souza Vilela, D.L.; Rocha, D.M.U.P.; Bressan, J.; Hermsdorff, H.H.M. Can resveratrol modulate sirtuins in obesity and related diseases? A systematic review of randomized controlled trials. Eur. J. Nutr., 2021, 60(6), 2961-2977. doi: 10.1007/s00394-021-02623-y PMID: 34251517
- Shabani, M.; Sadeghi, A.; Hosseini, H.; Teimouri, M.; Babaei Khorzoughi, R.; Pasalar, P.; Meshkani, R. Resveratrol alleviates obesity-induced skeletal muscle inflammation via decreasing M1 macrophage polarization and increasing the regulatory T cell population. Sci. Rep., 2020, 10(1), 3791. doi: 10.1038/s41598-020-60185-1 PMID: 32123188
- Huang, Y.; Zhu, X.; Chen, K.; Lang, H.; Zhang, Y.; Hou, P.; Ran, L.; Zhou, M.; Zheng, J.; Yi, L.; Mi, M.; Zhang, Q. Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway. Aging, 2019, 11(8), 2217-2240. doi: 10.18632/aging.101910 PMID: 30988232
- Wang, P.; Li, D.; Ke, W.; Liang, D.; Hu, X.; Chen, F. Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice. Int. J. Obes., 2020, 44(1), 213-225. doi: 10.1038/s41366-019-0332-1 PMID: 30718820
- Wang, P.; Gao, J.; Ke, W.; Wang, J.; Li, D.; Liu, R.; Jia, Y.; Wang, X.; Chen, X.; Chen, F.; Hu, X. Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota. Free Radic. Biol. Med., 2020, 156, 83-98. doi: 10.1016/j.freeradbiomed.2020.04.013 PMID: 32305646
- Castro-Rodríguez, D.C.; Reyes-Castro, L.A.; Vargas-Hernández, L.; Itani, N.; Nathanielsz, P.W.; Taylor, P.D.; Zambrano, E. Maternal obesity (MO) programs morphological changes in aged rat offspring small intestine in a sex dependent manner: Effects of maternal resveratrol supplementation. Exp. Gerontol., 2021, 154, 111511. doi: 10.1016/j.exger.2021.111511 PMID: 34371097
- Hsu, M.H.; Sheen, J.M.; Lin, I.C.; Yu, H.R.; Tiao, M.M.; Tain, Y.L.; Huang, L.T. Effects of maternal resveratrol on maternal high-fat diet/obesity with or without postnatal high-fat diet. Int. J. Mol. Sci., 2020, 21(10), 3428. doi: 10.3390/ijms21103428 PMID: 32408716
- Hillsley, A.; Chin, V.; Li, A.; McLachlan, C.S. Resveratrol for weight loss in obesity: An signs in ClinicalTrials.gov. Nutrients, 2022, 14(7), 1424. doi: 10.3390/nu14071424 PMID: 35406038
- Mousavi, S.M.; Milajerdi, A.; Sheikhi, A.; Kord-Varkaneh, H.; Feinle-Bisset, C.; Larijani, B.; Esmaillzadeh, A. Resveratrol supplementation significantly influences obesity measures: A systematic review and doseresponse meta-analysis of randomized controlled trials. Obes. Rev., 2019, 20(3), 487-498. doi: 10.1111/obr.12775 PMID: 30515938
- Arzola-Paniagua, M.A.; García-Salgado López, E.R.; Calvo-Vargas, C.G.; Guevara-Cruz, M. Efficacy of an orlistat-resveratrol combination for weight loss in subjects with obesity: A randomized controlled trial. Obesity, 2016, 24(7), 1454-1463. doi: 10.1002/oby.21523 PMID: 27221771
- Sathyanarayana, A.R.; Lu, C.K.; Liaw, C.C.; Chang, C.C.; Han, H.Y.; Green, B.D.; Huang, W.J.; Huang, C.; He, W.D.; Lee, L.C.; Liu, H.K. 1,2,3,4,6-Penta-O-galloyl-d-glucose interrupts the early adipocyte lifecycle and attenuates adiposity and hepatic steatosis in mice with diet-induced obesity. Int. J. Mol. Sci., 2022, 23(7), 4052. doi: 10.3390/ijms23074052 PMID: 35409415
- Sharifi-Rad, M.; Varoni, E.M.; Iriti, M.; Martorell, M.; Setzer, W.N.; del Mar Contreras, M.; Salehi, B.; Soltani-Nejad, A.; Rajabi, S.; Tajbakhsh, M.; Sharifi-Rad, J. Carvacrol and human health: A comprehensive review. Phytother. Res., 2018, 32(9), 1675-1687. doi: 10.1002/ptr.6103 PMID: 29744941
- Spalletta, S.; Flati, V.; Toniato, E.; Di Gregorio, J.; Marino, A.; Pierdomenico, L.; Marchisio, M.; DOrazi, G.; Cacciatore, I.; Robuffo, I. Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression. PLoS One, 2018, 13(11), e0206894. doi: 10.1371/journal.pone.0206894 PMID: 30418986
- Cho, S.; Choi, Y.; Park, S.; Park, T. Carvacrol prevents diet-induced obesity by modulating gene expressions involved in adipogenesis and inflammation in mice fed with high-fat diet. J. Nutr. Biochem., 2012, 23(2), 192-201. doi: 10.1016/j.jnutbio.2010.11.016 PMID: 21447440
- Brahma Naidu, P.; Uddandrao, V.V.S.; Ravindar Naik, R.; Suresh, P.; Meriga, B.; Begum, M.S.; Pandiyan, R.; Saravanan, G. Ameliorative potential of gingerol: Promising modulation of inflammatory factors and lipid marker enzymes expressions in HFD induced obesity in rats. Mol. Cell. Endocrinol., 2016, 419, 139-147. doi: 10.1016/j.mce.2015.10.007 PMID: 26493465
- Saravanan, G.; Ponmurugan, P.; Deepa, M.A.; Senthilkumar, B. Anti-obesity action of gingerol: Effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet. J. Sci. Food Agric., 2014, 94(14), 2972-2977. doi: 10.1002/jsfa.6642 PMID: 24615565
- Sanders, O.D.; Rajagopal, J.A.; Rajagopal, L. Menthol to induce non-shivering thermogenesis via TRPM8/PKA signaling for treatment of obesity. J. Obes. Metab. Syndr., 2021, 30(1), 4-11. doi: 10.7570/jomes20038 PMID: 33071240
- Khare, P.; Mangal, P.; Baboota, R.K.; Jagtap, S.; Kumar, V.; Singh, D.P.; Boparai, R.K.; Sharma, S.S.; Khardori, R.; Bhadada, S.K.; Kondepudi, K.K.; Chopra, K.; Bishnoi, M. Involvement of glucagon in preventive effect of menthol against high fat diet induced obesity in mice. Front. Pharmacol., 2018, 9, 1244. doi: 10.3389/fphar.2018.01244 PMID: 30505271
- Vizin, R.C.L.; Motzko-Soares, A.C.P.; Armentano, G.M.; Ishikawa, D.T.; Cruz-Neto, A.P.; Carrettiero, D.C.; Almeida, M.C. Short-term menthol treatment promotes persistent thermogenesis without induction of compensatory food consumption in Wistar rats: Implications for obesity control. J. Appl. Physiol., 2018, 124(3), 672-683. doi: 10.1152/japplphysiol.00770.2017 PMID: 29357504
- Li, W.; Zeng, H.; Xu, M.; Huang, C.; Tao, L.; Li, J.; Zhang, T.; Chen, H.; Xia, J.; Li, C.; Li, X. Oleanolic acid improves obesity-related inflammation and insulin resistance by regulating macrophages activation. Front. Pharmacol., 2021, 12, 697483. doi: 10.3389/fphar.2021.697483 PMID: 34393781
- Djeziri, F.Z.; Belarbi, M.; Murtaza, B.; Hichami, A.; Benammar, C.; Khan, N.A. Oleanolic acid improves diet-induced obesity by modulating fat preference and inflammation in mice. Biochimie, 2018, 152, 110-120. doi: 10.1016/j.biochi.2018.06.025 PMID: 29966735
- de Melo, C.L.; Queiroz, M.G.R.; Fonseca, S.G.C.; Bizerra, A.M.C.; Lemos, T.L.G.; Melo, T.S.; Santos, F.A.; Rao, V.S. Oleanolic acid, a natural triterpenoid improves blood glucose tolerance in normal mice and ameliorates visceral obesity in mice fed a high-fat diet. Chem. Biol. Interact., 2010, 185(1), 59-65. doi: 10.1016/j.cbi.2010.02.028 PMID: 20188082
- Sung, H.Y.; Kang, S.W.; Kim, J.L.; Li, J.; Lee, E.S.; Gong, J.H.; Han, S.J.; Kang, Y.H. Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes. Nutr. Res., 2010, 30(12), 831-839. doi: 10.1016/j.nutres.2010.10.001 PMID: 21147366
- Salehi, B.; Mishra, A.P.; Shukla, I.; Sharifi-Rad, M.; Contreras, M.M.; Segura-Carretero, A.; Fathi, H.; Nasrabadi, N.N.; Kobarfard, F.; Sharifi-Rad, J. Thymol, thyme, and other plant sources: Health and potential uses. Phytother. Res., 2018, 32(9), 1688-1706. doi: 10.1002/ptr.6109 PMID: 29785774
- Nagoor Meeran, M.F.; Javed, H.; Al Taee, H.; Azimullah, S.; Ojha, S.K. Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for its therapeutic potential and pharmaceutical development. Front. Pharmacol., 2017, 8, 380. doi: 10.3389/fphar.2017.00380 PMID: 28694777
- Habtemariam, S. Antidiabetic potential of monoterpenes: A case of small molecules punching above their weight. Int. J. Mol. Sci., 2017, 19(1), 4. doi: 10.3390/ijms19010004 PMID: 29267214
- Haque, M.R.; Ansari, S.H.; Najmi, A.K.; Ahmad, M.A. Monoterpene phenolic compound thymol prevents high fat diet induced obesity in murine model. Toxicol. Mech. Methods, 2014, 24(2), 116-123. doi: 10.3109/15376516.2013.861888 PMID: 24175857
- Neilson, A.P.; Goodrich, K.M.; Ferruzzi, M.G. Bioavailability and Metabolism of Bioactive Compounds From Foods.Nutrition in the Prevention and Treatment of Disease; Delahanty, F.E., Ed.; Academic Press, 2017, pp. 301-319. doi: 10.1016/B978-0-12-802928-2.00015-1
- Basak, S.; Duttaroy, A.K. Conjugated linoleic acid and its beneficial effects in obesity, cardiovascular disease, and cancer. Nutrients, 2020, 12(7), 1913. doi: 10.3390/nu12071913 PMID: 32605287
- Ibrahim, K.S.; El-Sayed, E.M. Dietary conjugated linoleic acid and medium-chain triglycerides for obesity management. J. Biosci., 2021, 46(1), 12. doi: 10.1007/s12038-020-00133-3 PMID: 33709964
- Sun, Y.; Hou, X.; Li, L.; Tang, Y.; Zheng, M.; Zeng, W.; Lei, X. Improving obesity and lipid metabolism using conjugated linoleic acid. Vet. Med. Sci., 2022, 8(6), 2538-2544. doi: 10.1002/vms3.921 PMID: 36104831
- Liu, L.; He, Y.; Wang, K.; Miao, J.; Zheng, Z. Metagenomics approach to the intestinal microbiome structure and function in high fat diet-induced obesity in mice fed with conjugated linoleic acid (CLA). Food Funct., 2020, 11(11), 9729-9739. doi: 10.1039/D0FO02112A PMID: 33063083
- OReilly, M.E.; Lenighan, Y.M.; Dillon, E.; Kajani, S.; Curley, S.; Bruen, R.; Byrne, R.; Heslin, A.M.; Moloney, A.P.; Roche, H.M.; McGillicuddy, F.C. Conjugated linoleic acid and alpha linolenic acid improve cholesterol homeostasis in obesity by modulating distinct hepatic protein pathways. Mol. Nutr. Food Res., 2020, 64(7), 1900599. doi: 10.1002/mnfr.201900599 PMID: 31917888
- Zhuang, P.; Shou, Q.; Wang, W.; He, L.; Wang, J.; Chen, J.; Zhang, Y.; Jiao, J. Essential fatty acids linoleic acid and α-linolenic acid sex-dependently regulate glucose homeostasis in obesity. Mol. Nutr. Food Res., 2018, 62(17), 1800448. doi: 10.1002/mnfr.201800448 PMID: 29935107
- Oh, S.L.; Lee, S.R.; Kim, J.S. Effects of conjugated linoleic acid/n-3 and resistance training on muscle quality and expression of atrophy-related ubiquitin ligases in middle-aged mice with high-fat dietinduced obesity. J. Exerc. Nutrition Biochem., 2017, 21(3), 11-18. doi: 10.20463/jenb.2017.0028 PMID: 29036761
- Dumont, J.; Goumidi, L.; Grenier-Boley, B.; Cottel, D.; Marécaux, N.; Montaye, M.; Wagner, A.; Arveiler, D.; Simon, C.; Ferrières, J.; Ruidavets, J.B.; Amouyel, P.; Dallongeville, J.; Meirhaeghe, A. Dietary linoleic acid interacts with FADS1 genetic variability to modulate HDL-cholesterol and obesity-related traits. Clin. Nutr., 2018, 37(5), 1683-1689. doi: 10.1016/j.clnu.2017.07.012 PMID: 28774683
- Segovia, S.A.; Vickers, M.H.; Zhang, X.D.; Gray, C.; Reynolds, C.M. Maternal supplementation with conjugated linoleic acid in the setting of diet-induced obesity normalises the inflammatory phenotype in mothers and reverses metabolic dysfunction and impaired insulin sensitivity in offspring. J. Nutr. Biochem., 2015, 26(12), 1448-1457. doi: 10.1016/j.jnutbio.2015.07.013 PMID: 26318151
- Kim, Y.; Kim, D.; Good, D.J.; Park, Y. Effects of postweaning administration of conjugated linoleic acid on development of obesity in nescient basic helix-loop-helix 2 knockout mice. J. Agric. Food Chem., 2015, 63(21), 5212-5223. doi: 10.1021/acs.jafc.5b00840 PMID: 25976059
- Kim, J.H.; Gilliard, D.; Good, D.J.; Park, Y. Preventive effects of conjugated linoleic acid on obesity by improved physical activity in nescient basic helix-loop-helix 2 knockout mice during growth period. Food Funct., 2012, 3(12), 1280-1285. doi: 10.1039/c2fo30103b PMID: 22944770
- den Hartigh, L. Conjugated linoleic acid effects on cancer, obesity, and atherosclerosis: A review of pre-clinical and human trials with current perspectives. Nutrients, 2019, 11(2), 370. doi: 10.3390/nu11020370 PMID: 30754681
- Liang, C.W.; Cheng, H.Y.; Lee, Y.H.; Liou, T.H.; Liao, C.D.; Huang, S.W. Effects of conjugated linoleic acid and exercise on body composition and obesity: A systematic review and meta-analysis. Nutr. Rev., 2022, 81(4), 397-415. doi: 10.1093/nutrit/nuac060 PMID: 36048508
- He, Y.; Xu, K.; Li, Y.; Chang, H.; Liao, X.; Yu, H.; Tian, T.; Li, C.; Shen, Y.; Wu, Q.; Liu, X.; Shi, L. Metabolomic changes upon conjugated linoleic acid supplementation and predictions of body composition responsiveness. J. Clin. Endocrinol. Metab., 2022, 107(9), 2606-2615. doi: 10.1210/clinem/dgac367 PMID: 35704027
- Chang, H.; Gan, W.; Liao, X.; Wei, J.; Lu, M.; Chen, H.; Wang, S.; Ma, Y.; Wu, Q.; Yu, Y.; Liu, X. Conjugated linoleic acid supplements preserve muscle in high-body-fat adults: A double-blind, randomized, placebo trial. Nutr. Metab. Cardiovasc. Dis., 2020, 30(10), 1777-1784. doi: 10.1016/j.numecd.2020.05.029 PMID: 32684362
- Mądry, E.; Malesza, I.J.; Subramaniapillai, M.; Czochralska-Duszyńska, A.; Walkowiak, M.; Miśkiewicz-Chotnicka, A.; Walkowiak, J.; Lisowska, A. Body fat changes and liver safety in obese and overweight women supplemented with conjugated linoleic acid: A 12-week randomised, double-blind, placebo-controlled trial. Nutrients, 2020, 12(6), 1811. doi: 10.3390/nu12061811 PMID: 32560516
- Esmaeili Shahmirzadi, F.; Ghavamzadeh, S.; Zamani, T. The effect of conjugated linoleic acid supplementation on body composition, serum insulin and leptin in obese adults. Arch. Iran Med., 2019, 22(5), 255-261. PMID: 31256599
- Namazi, N.; Irandoost, P.; Larijani, B.; Azadbakht, L. The effects of supplementation with conjugated linoleic acid on anthropometric indices and body composition in overweight and obese subjects: A systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr., 2019, 59(17), 2720-2733. doi: 10.1080/10408398.2018.1466107 PMID: 29672124
- Guo, X.; Zhang, T.; Shi, L.; Gong, M.; Jin, J.; Zhang, Y.; Liu, R.; Chang, M.; Jin, Q.; Wang, X. The relationship between lipid phytochemicals, obesity and its related chronic diseases. Food Funct., 2018, 9(12), 6048-6062. doi: 10.1039/C8FO01026A PMID: 30427004
- Lee, D.; Lee, J.H.; Kim, B.H.; Lee, S.; Kim, D.W.; Kang, K.S. Phytochemical combination (p-Synephrine, p-Octopamine Hydrochloride, and Hispidulin) for improving obesity in obese mice induced by high-fat diet. Nutrients, 2022, 14(10), 2164. doi: 10.3390/nu14102164 PMID: 35631305
- Hirotani, Y.; Fukamachi, J.; Ueyama, R.; Urashima, Y.; Ikeda, K. Effects of capsaicin coadministered with eicosapentaenoic acid on obesity-related dysregulation in high-fat-fed mice. Biol. Pharm. Bull., 2017, 40(9), 1581-1585. doi: 10.1248/bpb.b17-00247 PMID: 28867743
- Zhao, L.; Cen, F.; Tian, F.; Li, M.J.; Zhang, Q.; Shen, H.Y.; Shen, X.C.; Zhou, M.M.; Du, J. Combination treatment with quercetin and resveratrol attenuates high fat diet-induced obesity and associated inflammation in rats via the AMPKα1/SIRT1 signaling pathway. Exp. Ther. Med., 2017, 14(6), 5942-5948. doi: 10.3892/etm.2017.5331 PMID: 29285143
- Zhuang, T.; Liu, X.; Wang, W.; Song, J.; Zhao, L.; Ding, L.; Yang, L.; Zhou, M. Dose-Related urinary metabolic alterations of a combination of quercetin and resveratrol-treated high-fat diet fed rats. Front. Pharmacol., 2021, 12, 655563. doi: 10.3389/fphar.2021.655563 PMID: 33935771
- Zhu, M.; Zhou, F.; Ouyang, J.; Wang, Q.; Li, Y.; Wu, J.; Huang, J.; Liu, Z. Combined use of epigallocatechin-3-gallate (EGCG) and caffeine in low doses exhibits marked anti-obesity synergy through regulation of gut microbiota and bile acid metabolism. Food Funct., 2021, 12(9), 4105-4116. doi: 10.1039/D0FO01768J PMID: 33977918
- Yang, Z.; Zhu, M.; Zhang, Y.; Wen, B.; An, H.; Ou, X.; Xiong, Y.; Lin, H.; Liu, Z.; Huang, J. Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats. Phytother. Res., 2019, 33(4), 1019-1026. doi: 10.1002/ptr.6295 PMID: 30746789
- Liu, H.; Guan, H.; Tan, X.; Jiang, Y.; Li, F.; Sun-Waterhouse, D.; Li, D. Enhanced alleviation of insulin resistance via the IRS-1/Akt/FOXO1 pathway by combining quercetin and EGCG and involving miR-27a-3p and miR-965p. Free Radic. Biol. Med., 2022, 181, 105-117. doi: 10.1016/j.freeradbiomed.2022.02.002 PMID: 35124182
- Ohara, T.; Muroyama, K.; Yamamoto, Y.; Murosaki, S. Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: A randomized double-blind placebo-controlled trial. Nutr. J., 2015, 15(1), 6. doi: 10.1186/s12937-016-0123-7 PMID: 26786000
- Ohara, T.; Muroyama, K.; Yamamoto, Y.; Murosaki, S. A combination of glucosyl hesperidin and caffeine exhibits an anti-obesity effect by inhibition of hepatic lipogenesis in mice. Phytother. Res., 2015, 29(2), 310-316. doi: 10.1002/ptr.5258 PMID: 25409936
- Rebello, C.J.; Greenway, F.L.; Zhang, D.; Johnson, W.D.; Patterson, E.; Raum, W. Sympathomimetic increases resting energy expenditure following bariatric surgery: A randomized controlled clinical trial. Obesity, 2022, 30(4), 874-883. doi: 10.1002/oby.23384 PMID: 35244344
- Bracale, R.; Petroni, M.L.; Davinelli, S.; Bracale, U.; Scapagnini, G.; Carruba, M.O.; Nisoli, E. Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: Results of a double blind, randomised clinical trial in morbidly obese females. PLoS One, 2014, 9(6), e98244. doi: 10.1371/journal.pone.0098244 PMID: 24905629
- Ogawa, K.; Hirose, S.; Nagaoka, S.; Yanase, E. Interaction between tea polyphenols and bile acid inhibits micellar cholesterol solubility. J. Agric. Food Chem., 2016, 64(1), 204-209. doi: 10.1021/acs.jafc.5b05088 PMID: 26651358
- Sakakibara, T.; Sawada, Y.; Wang, J.; Nagaoka, S.; Yanase, E. Molecular mechanism by which tea catechins decrease the micellar solubility of cholesterol. J. Agric. Food Chem., 2019, 67(25), 7128-7135. doi: 10.1021/acs.jafc.9b02265 PMID: 31150244
- Ashigai, H.; Taniguchi, Y.; Suzuki, M.; Ikeshima, E.; Kanaya, T.; Zembutsu, K.; Tomita, S.; Miyake, M.; Fukuhara, I. Fecal lipid excretion after consumption of a black tea polyphenol containing beverage-randomized, placebo-controlled, double-blind, crossover study. Biol. Pharm. Bull., 2016, 39(5), 699-704. doi: 10.1248/bpb.b15-00662 PMID: 26887502
- Hamauzu, Y.; Suwannachot, J. Non-extractable polyphenols and in vitro bile acid-binding capacity of dried persimmon (Diospyros kaki) fruit. Food Chem., 2019, 293, 127-133. doi: 10.1016/j.foodchem.2019.04.092 PMID: 31151592
- Huang, J.; Feng, S.; Liu, A.; Dai, Z.; Wang, H.; Reuhl, K.; Lu, W.; Yang, C.S. Green tea polyphenol EGCG alleviates metabolic abnormality and fatty liver by decreasing bile acid and lipid absorption in mice. Mol. Nutr. Food Res., 2018, 62(4), 1700696. doi: 10.1002/mnfr.201700696 PMID: 29278293
- Ikeda, I.; Yamahira, T.; Kato, M.; Ishikawa, A. Black-tea polyphenols decrease micellar solubility of cholesterol in vitro and intestinal absorption of cholesterol in rats. J. Agric. Food Chem., 2010, 58(15), 8591-8595. doi: 10.1021/jf1015285 PMID: 20681647
- Ikeda, I.; Kobayashi, M.; Hamada, T.; Tsuda, K.; Goto, H.; Imaizumi, K.; Nozawa, A.; Sugimoto, A.; Kakuda, T. Heat-epimerized tea catechins rich in gallocatechin gallate and catechin gallate are more effective to inhibit cholesterol absorption than tea catechins rich in epigallocatechin gallate and epicatechin gallate. J. Agric. Food Chem., 2003, 51(25), 7303-7307. doi: 10.1021/jf034728l PMID: 14640575
Supplementary files
